ReviewFrontiers in neurology2020
Moyamoya Disease Associated With Morning Glory Disc Anomaly and Other Ophthalmic Findings: A Mini-Review.
Review in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 24 citations in OpenAlex.
- Case Report: Sturge-Weber syndrome with contralateral morning glory syndrome.Frontiers in medicine · 2026Article
- Management of large submacular hemorrhage in a patient undergoing neurosurgical intervention for moyamoya.Digital journal of ophthalmology : DJO · 2025Article
- Morning Glory Disc Anomaly: Expanding the MR Phenotype.AJNR. American journal of neuroradiology · 2024Article
- Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist.Journal of ophthalmic inflammation and infection · 2024Review
- Congenital Optic Disc Anomalies: Insights from Multimodal Imaging.Journal of clinical medicine · 2024Review
- Screening of Moyamoya Disease From Retinal Photographs: Development and Validation of Deep Learning Algorithms.Stroke · 2024Observational
- When Pediatric Headaches Are Not Benign-Eye Findings.Children (Basel, Switzerland) · 2023Article
- Moyamoya-Like Vasculopathy and Orbital Trauma: An Association.Neuro-ophthalmology (Aeolus Press) · 2023Article
- Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome.International journal of ophthalmology · 2022Article
- Cephalic/cardiac neural crest cell and moyamoya disease.The neuroradiology journal · 2021Review
- Clinical and Echographic Features of Morning Glory Disc Anomaly in Children: A Retrospective Study of 249 Chinese Patients.Frontiers in medicine · 2021Article
- Quantitative Optical Coherence Tomography Angiography in Patients with Moyamoya Vasculopathy: A Pilot Study.Neuro-ophthalmology (Aeolus Press) · 2021Article
- An unusual association of Morning Glory Syndrome with chronic myeloid leukemia-Philadelphia chromosome.Journal of family medicine and primary care · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moyamoya disease (MMD) is a chronic cerebrovascular disease that frequently results in intracranial ischemia or hemorrhage. Its concurrence with varying ophthalmic findings is relatively rare yet may lead to irreversible blindness. We performed a search and review of the literature to characterize the relevance of MMD (excluding moyamoya syndrome) and ophthalmic findings. As a result, a total of 38 articles identified from PubMed and Web of Science were included in this mini-review. Patients with MMD sometimes present with decreased visual acuity or visual field defects before the onset of symptomatic cerebrovascular dysfunction. The most predominant ophthalmic condition in MMD patients is the morning glory disc anomaly (MGDA). Deficiency during neuroectodermal genesis and subsequent mesodermal changes may be responsible for the association between these two diseases. Thus, it may be beneficial for patients with MGDA to receive cerebral vascular examinations as the precaution against life-threatening intracranial angiopathy. Other ophthalmic findings reported in cases of MMD include retinal vascular occlusion, optic disc pallor, cortical blindness, etc. For most of the patients with MMD, retinal examinations would be recommended to prevent potential loss of vision. It is essential for both neurologists and ophthalmologists to be aware of the correlation between cerebrovascular diseases such as MMD and ocular manifestations to achieve a comprehensive diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.